Skip to content
Screener

LeMaitre Vascular LMAT Q1 2026 earnings

Reported May 5, 2026 · After market close

Revenue$66.6MMiss by $122.6K
EPS$0.68Beat by $0.02
Revenue estimate$66.7M
EPS estimate$0.66

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$67.4M
EPS estimate$0.69

Financials

Q1 2026

Income statement

See full
Revenue$66.6M+11.2%
Gross profit$48.4M+16.8%
Operating income$17.8M+40.8%
Net income$15.7M+42.4%
EPS (diluted)$0.68+41.7%

Balance sheet

See full
Cash & equivalents$26.9M+6.0%
Total debt$20.9M+20.6%
Total equity$406.6M+17.0%
Total assets$629.5M+13.2%

Cash flow

See full
Operating cash flow$15.1M+67.0%
CapEx$2.8M+101%
Free cash flow$12.3M+60.8%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$2.49B+31.4%
Enterprise value$2.48B+31.6%
P/E39.8×-2.1×
P/S9.7×+1.3×

Profitability

See full
Gross margin72.4%+3.6pp
Operating margin28.5%+5.1pp
Net margin24.3%+4.4pp
FCF margin30.9%+12.7pp

Returns & leverage

See full
Return on equity16.5%+2.8pp
Debt / equity0.1×0.0×
Current ratio14.3×-2.2×

FAQ

When did LeMaitre Vascular report Q1 2026 earnings?
LeMaitre Vascular (LMAT) reported Q1 2026 earnings on May 5, 2026 after market close.
What were LeMaitre Vascular's Q1 2026 revenue and EPS?
LeMaitre Vascular reported revenue of $66.6M and eps of $0.68 for Q1 2026.
Did LeMaitre Vascular beat estimates in Q1 2026?
Revenue missed the consensus estimate of $66.7M by $122.6K. EPS beat the consensus estimate of $0.66 by $0.02.
How did LeMaitre Vascular's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 11.2% from $59.9M a year earlier and eps grew 41.7% from $0.48.
Where can I find LeMaitre Vascular's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-206578) and the 10-Q periodic report (0001193125-26-207500) directly on SEC EDGAR. The filing index links above go to sec.gov.